Research output per year
Research output per year
Personal profile
Research interests
Receptor-targeted non-viral DNA vectors; gene therapy studies in immune tolerance and genetic disorders; and development of peptide nanoparticles for drug delivery.
Research interests (short)
Receptor-targeted non-viral DNA vectors; gene therapy studies in immune tolerance and genetic disorders; and development of peptide nanoparticles for drug delivery.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Louise Collins is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
-
Evaluation of Several DNA Expression Constructs for the Level and Longevity of Expression of the Pancreatic Transcription Factor pdx1 in Rat Liver
Cim, A., Sawyer, G. J., Zhang, H., Su, H., Collins, L., Antoniou, M., Lipps, H. & Fabre, J. W., 2010, In: Human Gene Therapy. 21, 4, p. 517 - 517 1 p.Research output: Contribution to journal › Meeting abstract
-
Nonviral Delivery of the Rat PDX1 Gene to Rat Liver For the In Vivo Transdifferentiation of Liver Cells to Pancreatic Beta-Cells
Cim, A., Sawyer, G., Zhang, X., Su, H., Collins, L., Jones, P., Antoniou, M., Lipps, H. J. & Fabre, J., 2010, In: Human Gene Therapy. 21, 9, p. 1182 - 1182 1 p.Research output: Contribution to journal › Meeting abstract
-
Self-Assembly of Peptides into Spherical Nanoparticles for Delivery of Hydrophilic Moieties to the Cytosol
Collins, L., Parker, A. L., Gehman, J. D., Eckley, L., Perugini, M. A., Separovic, F. & Fabre, J. W., 25 May 2010, In: ACS Nano. 4, 5, p. 2856 - 2864 9 p.Research output: Contribution to journal › Article › peer-review
26 Citations (Scopus) -
(LYS)(16)-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells
Parker, A. L., Eckley, L., Singh, S., Preece, J. A., Collins, L. & Fabre, J. W., Sept 2007, In: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS. 1770, 9, p. 1331 - 1337 7 p.Research output: Contribution to journal › Article › peer-review
31 Citations (Scopus) -
In vivo suppression of major histocompatibility complex class II expression on porcine vascular endothelial cells by an HMG-CoA reductase inhibitor
Geissler, I., Collins, L., Schofield, R. & Fabre, J. W., Mar 2006, In: Transplantation. 81, 6, p. 922 - 926 5 p.Research output: Contribution to journal › Article › peer-review
18 Citations (Scopus)
-
Non-viral gene therapy for the liver for Wilson's disease
Collins, L. (Primary Investigator), Fabre, J. (Primary Investigator) & Lipps, H. (Co-Investigator)
Project: Research
-
Non-viral gene delivery of donor MHC antigens to the liver ___??_____: A novel approach to donor-specific immunoregulation.
Collins, L. (Primary Investigator) & Fabre, J. (Primary Investigator)
1/07/2010 → 30/06/2011
Project: Research
-
Non-viral gene delivery to the rat liver for the in vivo transdifferentiation of hepatocytes into pancreatic b cells
Collins, L. (Primary Investigator), Amiel, S. (Co-Investigator), Antoniou, M. (Co-Investigator), Fabre, J. (Co-Investigator), Jones, P. (Co-Investigator) & Lipps, H. (Co-Investigator)
1/11/2009 → 31/10/2011
Project: Research
-
Non-viral genetherapy for Wilson's disease
Collins, L. (Primary Investigator), Fabre, J. (Primary Investigator) & Lipps, H. (Co-Investigator)
1/01/2009 → 31/12/2010
Project: Research
-
Non-viral gene delivery to liver for transdifferentiation of heatocytes into pancreatic beta cells for type 1 diabetes
Collins, L. (Primary Investigator), Fabre, J. (Primary Investigator) & Jones, P. (Primary Investigator)
1/12/2008 → 31/05/2011
Project: Research